Detalles de la búsqueda
1.
CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Acta Pharmacol Sin
; 43(1): 121-132, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767379
2.
Protective effects of S-carvedilol on doxorubicin-induced damages to human umbilical vein endothelial cells and rats.
J Appl Toxicol
; 39(8): 1233-1244, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31066085
3.
Author Correction: CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Acta Pharmacol Sin
; 43(7): 1884, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087232
4.
Virtual Screening of Potential RoxS Inhibitors and Evaluation of Their Antimicrobial Activity in Combination with Antibiotics against Clinically Resistant Bacteria.
Antibiotics (Basel)
; 12(9)2023 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760718
5.
Mutation in Transmembrane Domain 8 of Human Urate Transporter 1 Disrupts Uric Acid Recognition and Transport.
ACS Omega
; 7(38): 34621-34631, 2022 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36188325
6.
Versatile Nanodrugs Containing Glutathione and Heme Oxygenase 1 Inhibitors Enable Suppression of Antioxidant Defense System in a Two-Pronged Manner for Enhanced Photodynamic Therapy.
Adv Healthc Mater
; 10(19): e2100770, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34190424
7.
Structural Insights into the Atomistic Mechanisms of Uric Acid Recognition and Translocation of Human Urate Anion Transporter 1.
ACS Omega
; 5(51): 33421-33432, 2020 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403304
Resultados
1 -
7
de 7
1
Próxima >
>>